Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 6/20 | 0.49 |
| ▸ | NMT2 | O60551 | 5/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.49 |
| ▸ | GLP1R | P43220 | 8/20 | 0.44 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19867245 | 1.00 | NMT1 (0.49) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL17375884 | 0.98 | NMT1 (0.47) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL21100058 | 0.98 | NMT1 (0.47) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL19308062 | 0.97 | NOD1 (0.51) | NMT1NMT2NOD1GLP1R | |
| SCHEMBL17682348 | 0.96 | NOD1 (0.52) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL16156108 | 0.95 | NOD1 (0.49) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL16156102 | 0.95 | NOD1 (0.49) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL21099794 | 0.93 | NMT1 (0.44) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL21418066 | 0.91 | NOD1 (0.47) | NMT1NMT2NOD1GLP1RGLO1 | |
| SCHEMBL20375263 | 0.91 | NOD1 (0.47) | NMT1NMT2NOD1GLP1RGLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9751927-B2 | Stable, protracted GLP-1/glucagon receptor co-agonists for medical use | NOVO NORDISK A/S (DK) | 2017-09-05 | — | — | US | disclosed |